ADIPOQ and endometrial cancer: In fact, in patients affected by breast and endometrial cancer, adiponectin levels are decreased; inversely, in patients affected by lung, prostate, gastric, liver, pancreatic and hematological, colon, and renal cancers adiponectin levels are increased.